Dr. Singerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3401 Enterprise Pkwy
Beachwood, OH 44122Phone+1 216-831-5700Fax+1 216-831-1959- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Surgical Retina and Vitreous, 1973 - 1974
- Mount Sinai Medical Center of ClevelandResidency, Ophthalmology, 1970 - 1973
- Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1969 - 1970
- Wayne State University School of MedicineClass of 1969
Certifications & Licensure
- MI State Medical License 1970 - Present
- OH State Medical License 1970 - 2026
- FL State Medical License 2008 - 2025
- PA State Medical License 2008 - 2024
- CT State Medical License 2008 - 2009
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion Start of enrollment: 2009 Nov 01
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsSwitching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular d...Joseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou, Thomas P Hull, Shawn A Lewis, David G Miller, Michael A Novak, Scott D Pendergast, Han...> ;International Journal of Retina and Vitreous. 2023 Feb 1
- One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.Coney, J., McCoy, J., Buxy Sinha, S., Sonbolian, N., Zhou, L., Hull, T., Lewis, S., Miller, D., Novak, M., Pendergast, S., Pham, H., Platt, S., Rao, L., Schartman, J.,...> ;Clinical Ophthalmology. 2023 Jan 1
- 13 citationsA Smart Mobile Application to Monitor Visual Function in Diabetic Retinopathy and Age-Related Macular Degeneration: The CLEAR Study.Rahul N. Khurana, Carol Hoang, Arshad M. Khanani, Nikolai Steklov, Lawrence J. Singerman> ;American Journal of Ophthalmology. 2021 Apr 5
- Join now to see all
Press Mentions
- Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
- Angiogenesis 2019 Session III: High Risk Non-Exudative AMDFebruary 12th, 2019
- Bascom Palmer Eye InstituteFebruary 9th, 2019
Professional Memberships
- Fellow
- Member
Hospital Affiliations
- Cleveland Clinic Akron GeneralAkron, Ohio
- Cleveland Clinic Hillcrest HospitalCleveland, Ohio
- University Hospitals Parma Medical CenterCleveland, Ohio
- VA Northeast Ohio Healthcare SystemCleveland, Ohio
External Links
- Websitehttp://www.retina-doctors.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: